Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01525420 · ClinicalTrials.gov registry record · NA

Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy

A NA study, sponsored by Fred Hutchinson Cancer Center.

Completed
Registry status
NA
Development phase
121
Enrollment target

NCT01525420 is a NA study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 121 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01525420, a NA study, has completed, sponsored by Fred Hutchinson Cancer Center.

COMPLETED
Registry status
NA
Development phase
121 participants
Enrollment target

Study Summary

The purpose of this study is to demonstrate that Acceptance Therapy (ACT's) implementation outcomes are at least as good as those of traditional cognitive behavioral therapy (CBT). Implementation outcomes: * end of treatment and 6-month follow-up data retention rates; * intervention implementation quality; * number \& length of calls completed. Comparison of each arm's implementation

Interventions

  • OTHER Cognitive Behavioral Therapy (CBT)
  • BEHAVIORAL Acceptance Therapy (ACT)

Trial Details

FieldValue
Enrollment Target 121 participants
Start Date 2012-03
Est. Completion 2013-03
Phase NA

Sponsor

Fred Hutchinson Cancer Center

483 total trials

What the Registry Record Tells You About NCT01525420

The ClinicalTrials.gov registry entry for NCT01525420 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy (CBT) is the first listed.

NCT01525420 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01525420 about?

NCT01525420 is a clinical study titled "Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy". The purpose of this study is to demonstrate that Acceptance Therapy (ACT's) implementation outcomes are at least as good as those of traditional cognitive behavioral therapy (CBT). Implementation outcomes: * end of treatment and 6-month follow-up data retention rates; * intervention implementation...

What is the current status of trial NCT01525420?

This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2012-03. Estimated completion is 2013-03.

What interventions are being tested in trial NCT01525420?

The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (OTHER), Acceptance Therapy (ACT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01525420?

This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.